TY - JOUR
T1 - Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy
AU - Chelko, Stephen P.
AU - Keceli, Gizem
AU - Carpi, Andrea
AU - Doti, Nunzianna
AU - Agrimi, Jacopo
AU - Asimaki, Angeliki
AU - Beti, Carlos Bueno
AU - Miyamoto, Matthew
AU - Amat-Codina, Nuria
AU - Bedja, Djahida
AU - Wei, An Chi
AU - Murray, Brittney
AU - Tichnell, Crystal
AU - Kwon, Chulan
AU - Calkins, Hugh
AU - James, Cynthia A.
AU - O'Rourke, Brian
AU - Halushka, Marc K.
AU - Melloni, Edon
AU - Saffitz, Jeffrey E.
AU - Judge, Daniel P.
AU - Ruvo, Menotti
AU - Kitsis, Richard N.
AU - Andersen, Peter
AU - Di Lisa, Fabio
AU - Paolocci, Nazareno
N1 - Funding Information:
This work was supported by the NIH [R01 HL136918 and R01 HL063030 (to N.P.)]; R01 HL137259 (to B.O.); R01 HL138475 (to R.N.K.); T32 AG058527 (G.K.); R01 HD086026 (to C.K.) and TEDCO [2015-MSCRFI-1622 to (P.A.)]; American Heart Association Career Development Award [19CDA34760185 (to S.P.C.) and 19CDA34760161 (to P.A.)], Innovative Project Award [18IPA34170446 to (P.A.)], and Grant-in-Aid [17GRNT33670405 to (M.H.)]; the Department of Defense [PR191593 (to R.N.K.)]; Leducq Transatlantic Network of Excellence [16CVD04 (to F.D.L.)]; Leducq [RA15CVD04 (to R.N.K.)]; University of Padova Strategico Grant “DYCENDI” and CNR Neuroscience Institute (to F.D.L.); the Magic That Matters Fund [internal JHU award (to N.P.)]; Heart Rhythm Society Cardiac Pacing and Electrophysiology Fellowship Award sponsored by an educational grant from St. Jude Medical (to S.P.C.); and the Gilead Research Scholars in Cardiovascular Disease Fund (to A.A.). The Johns Hopkins ARVD Program is supported by the Dr. Francis P. Chiaramonte Private Foundation; Foundation Leducq [16CVD02 (to H.C.)]; the Leyla Erkan Family Fund for ARVD Research; the Dr. Satish, Rupal, and Robin Shah ARVD Fund at Johns Hopkins; the Bogle Foundation; the Healing Hearts Foundation; the Campanella Family; the Patrick J. Harrison Family; the Peter French Memorial Foundation; and the Wilmerding Endowments.
Publisher Copyright:
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
PY - 2021/2/17
Y1 - 2021/2/17
N2 - Myocyte death occurs in many inherited and acquired cardiomyopathies, including arrhythmogenic cardiomyopathy (ACM), a genetic heart disease plagued by the prevalence of sudden cardiac death. Individuals with ACM and harboring pathogenic desmosomal variants, such as desmoglein-2 (DSG2), often show myocyte necrosis with progression to exercise-associated heart failure. Here, we showed that homozygous Dsg2 mutant mice (Dsg2mut/mut), a model of ACM, die prematurely during swimming and display myocardial dysfunction and necrosis. We detected calcium (Ca2+) overload in Dsg2mut/mut hearts, which induced calpain-1 (CAPN1) activation, association of CAPN1 with mitochondria, and CAPN1-induced cleavage of mitochondrial-bound apoptosis-inducing factor (AIF). Cleaved AIF translocated to the myocyte nucleus triggering large-scale DNA fragmentation and cell death, an effect potentiated by mitochondrial-driven AIF oxidation. Posttranslational oxidation of AIF cysteine residues was due, in part, to a depleted mitochondrial thioredoxin-2 redox system. Hearts from exercised Dsg2mut/mut mice were depleted of calpastatin (CAST), an endogenous CAPN1 inhibitor, and overexpressing CAST in myocytes protected against Ca2+ overload-induced necrosis. When cardiomyocytes differentiated from Dsg2mut/mut embryonic stem cells (ES-CMs) were challenged with β-adrenergic stimulation, CAPN1 inhibition attenuated CAPN1-induced AIF truncation. In addition, pretreatment of Dsg2mut/mut ES-CMs with an AIF-mimetic peptide, mirroring the cyclophilin-A (PPIA) binding site of AIF, blocked PPIA-mediated AIF-nuclear translocation, and reduced both apoptosis and necrosis. Thus, preventing CAPN1-induced AIF-truncation or barring binding of AIF to the nuclear chaperone, PPIA, may avert myocyte death and, ultimately, disease progression to heart failure in ACM and likely other forms of cardiomyopathies.
AB - Myocyte death occurs in many inherited and acquired cardiomyopathies, including arrhythmogenic cardiomyopathy (ACM), a genetic heart disease plagued by the prevalence of sudden cardiac death. Individuals with ACM and harboring pathogenic desmosomal variants, such as desmoglein-2 (DSG2), often show myocyte necrosis with progression to exercise-associated heart failure. Here, we showed that homozygous Dsg2 mutant mice (Dsg2mut/mut), a model of ACM, die prematurely during swimming and display myocardial dysfunction and necrosis. We detected calcium (Ca2+) overload in Dsg2mut/mut hearts, which induced calpain-1 (CAPN1) activation, association of CAPN1 with mitochondria, and CAPN1-induced cleavage of mitochondrial-bound apoptosis-inducing factor (AIF). Cleaved AIF translocated to the myocyte nucleus triggering large-scale DNA fragmentation and cell death, an effect potentiated by mitochondrial-driven AIF oxidation. Posttranslational oxidation of AIF cysteine residues was due, in part, to a depleted mitochondrial thioredoxin-2 redox system. Hearts from exercised Dsg2mut/mut mice were depleted of calpastatin (CAST), an endogenous CAPN1 inhibitor, and overexpressing CAST in myocytes protected against Ca2+ overload-induced necrosis. When cardiomyocytes differentiated from Dsg2mut/mut embryonic stem cells (ES-CMs) were challenged with β-adrenergic stimulation, CAPN1 inhibition attenuated CAPN1-induced AIF truncation. In addition, pretreatment of Dsg2mut/mut ES-CMs with an AIF-mimetic peptide, mirroring the cyclophilin-A (PPIA) binding site of AIF, blocked PPIA-mediated AIF-nuclear translocation, and reduced both apoptosis and necrosis. Thus, preventing CAPN1-induced AIF-truncation or barring binding of AIF to the nuclear chaperone, PPIA, may avert myocyte death and, ultimately, disease progression to heart failure in ACM and likely other forms of cardiomyopathies.
UR - http://www.scopus.com/inward/record.url?scp=85101677083&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101677083&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.abf0891
DO - 10.1126/scitranslmed.abf0891
M3 - Article
C2 - 33597260
AN - SCOPUS:85101677083
SN - 1946-6234
VL - 13
JO - Science translational medicine
JF - Science translational medicine
IS - 581
M1 - eabf0891
ER -